Wu said that Quantum BioPharma (NASDAQ: QNTM), a biopharmaceutical research and development company, announced that it has been approved by the board to purchase additional Bitcoin and other cryptocurrencies, with a total investment of $5 million, aimed at providing returns to shareholders and hedging against the depreciation of the dollar. Quantum stated that all crypto assets are managed by a compliant custodian and committed to adhering to relevant financial and auditing regulations. The company will continue to monitor market dynamics and adjust its holdings in a timely manner.